Resources Contact Us Home
Browse by Category: Main > Health & Medicine
Class Information
Number: 424/143.1
Name: Drug, bio-affecting and body treating compositions > Immunoglobulin, antiserum, antibody, or antibody fragment, except conjugate or complex of the same with nonimmunoglobulin material > Monoclonal antibody or fragment thereof (i.e., produced by any cloning technology) > Binds receptor
Description: Subject matter involving a monoclonal antibody or antigen-binding fragment thereof whose antigen-binding site(s) will combine with a free or cell-associated receptor.

Sub-classes under this class:

Class Number Class Name Patents
424/144.1 Receptor integral to or derived from a lymphocytic or lymphocytic-like cell (e.g., nk cell, etc.) 615

Patents under this class:

Patent Number Title Of Patent Date Issued
8603481 Therapeutic agents for solid tumors Dec. 10, 2013
8603476 Humanized anti-human .alpha.9-integrin antibody Dec. 10, 2013
8603473 Modified binding molecules comprising connecting peptides Dec. 10, 2013
8603466 Agonist antibodies against TSHR Dec. 10, 2013
8603465 Methods for treatment of polyposis Dec. 10, 2013
8597898 Fusion polypeptides capable of activating receptors Dec. 3, 2013
8597654 Adjuvant therapy with an anti-ERBB2 antibody conjugated to a maytansiniod Dec. 3, 2013
8597645 Cancer treatment with endothelin receptor antagonists Dec. 3, 2013
8597644 Method for treating psoriasis by administering an antibody to interleukin-6 receptor Dec. 3, 2013
8597643 Antibodies for binding to non-functional P2X.sub.7 receptors in trimeric form Dec. 3, 2013
8591900 Anti-CD40 antibodies Nov. 26, 2013
8591897 Anti-ERBB2 antibody adjuvant therapy Nov. 26, 2013
8591889 Human monoclonal antibodies specific for CD22 Nov. 26, 2013
8591888 Cadherin-11 EC1 domain antagonists for treating inflammatory joint disorders Nov. 26, 2013
8586714 Dual variable domain immunoglobulins and uses thereof Nov. 19, 2013
8586052 Vaccines based on targeting antigen to DCIR expressed on antigen-presenting cells Nov. 19, 2013
8586043 Methods for treating breast cancer with inhibitors of neurotensin activation of NTSR1 Nov. 19, 2013
8586041 Human monoclonal antibodies to epidermal growth factor receptor (EGFR) Nov. 19, 2013
8586039 Degraded TPO agonist antibody Nov. 19, 2013
8586035 Use of IL-23 antagonists for treatment of infection Nov. 19, 2013
8586033 Integrin .alpha..sub.IIb.beta..sub.3 specific antibodies and peptides Nov. 19, 2013
8580264 Subcutaneously administered anti-IL-6 receptor antibody Nov. 12, 2013
8580263 Anti-EGFR family antibodies, bispecific anti-EGFR family antibodies and methods of use thereof Nov. 12, 2013
8574573 Anti-IL12Rbeta1 antibodies and their use in treating autoimmune and inflammatory disorders Nov. 5, 2013
8574572 Method of treating pulmonary disease by administering an antibody to G-CSF receptor Nov. 5, 2013
8568725 Method of treating transplant rejection with an anti-CD40 antibody Oct. 29, 2013
8568721 Method of treating rheumatoid arthritis with an anti-IL-6R antibody Oct. 29, 2013
8568720 High concentration antibody-containing liquid formulation Oct. 29, 2013
8568718 Antibodies recognizing a carbohydrate containing epitope on CD-43 and CEA expressed on cancer cells and methods using same Oct. 29, 2013
8563696 Antibody specifically binding to c-Met Oct. 22, 2013
8563511 Treatment of pulmonary hypertension using an agent that inhibits a tissue factor pathway Oct. 22, 2013
8562992 Immunoglobulin variants and uses thereof Oct. 22, 2013
8562991 Antibody molecules that bind to IL-6 receptor Oct. 22, 2013
8562990 Method of treating psoriatic arthritis with an IL-6 receptor antibody Oct. 22, 2013
8562988 Strategies for improved cancer vaccines Oct. 22, 2013
8557244 Treatment of aggressive non-Hodgkins lymphoma with anti-CD20 antibody Oct. 15, 2013
8557243 EFGR antibodies comprising modular recognition domains Oct. 15, 2013
8557242 ERBB2 antibodies comprising modular recognition domains Oct. 15, 2013
8557240 Method for the treatment of inflammatory disorders Oct. 15, 2013
8551485 Anti-CD40 antibodies and methods of inhibiting proliferation of CD40 expressing cells Oct. 8, 2013
8551482 Compositions and methods for increasing muscle growth Oct. 8, 2013
8545843 Treatment of vasculitis Oct. 1, 2013
8540993 Methods of treatment using IL-18 receptor antigen binding proteins Sep. 24, 2013
8540986 Toll-like receptor 3 antagonists Sep. 24, 2013
8535670 Method of treating colorectal cancer tumor Sep. 17, 2013
8530627 Fc.gamma.RIIB specific antibodies and methods of use thereof Sep. 10, 2013
8529901 Composition of a first non-labeled monoclonal antibody binding to a tumor antigen and a non-cross reactive second monoclonal antibody labeled with a NIR fluorescence label Sep. 10, 2013
8524867 Optimized antibodies that target CD19 Sep. 3, 2013
8524865 Antibodies and immunoconjugates and uses therefor Sep. 3, 2013
8524672 Method for inhibiting BAFF-R activity Sep. 3, 2013

  Recently Added Patents
Method of forming solderable side-surface terminals of quad no-lead frame (QFN) integrated circuit packages
Compression molding method and reinforced thermoplastic parts molded thereby
Buckle (tube)
Method and system for electronic assistance in dispensing pharmaceuticals
Cell surface display, screening and production of proteins of interest
Method and system for dynamic digital rights bundling
Spacers for insulated glass units
  Randomly Featured Patents
Methods for improving the quality of epitaxially-grown semiconductor materials
Adjustable temperature compensating constant force shock absorber
Circuit functional test system and method
Method of processing coal gas
Method for preparing metallic superalloy articles having thermophysically melt incompatible alloying elements, without melting
Electric drive motor
Voltage controlled oscillator and sensitivity adjustment
Controlled release delivery device for pharmaceutical agents incorporating microbial polysaccharide gum
Apparatus for drying crop materials
Rodent trap